Posted on: 27 October, 2021
Researchers and clinicians have welcomed Federal Government funding to improve the diagnosis and treatment of high blood pressure.
The condition affects around 1 in 3 people in Australia, significantly increasing the risk of stroke, coronary heart disease, heart failure and chronic kidney disease.
Men are more likely to have uncontrolled high blood pressure, with 1 in 4 men suffering untreated high.....
Read more
Category: World-leading technology
Posted on: 18 October, 2021
Just over two years ago, Ian Hutchinson (Hutch) was cycling with a friend on Sydney’s northern beaches, taking part in an activity he regularly enjoyed with his mate. But that morning was to have a life-changing impact, with Hutch suffering a sudden cardiac arrest midway through the ride.
It was only the quick thinking of his friend Don MacKee and a group of bystanders who called triple 0 and immed.....
Read more
Category: Cardiovascular and Renal Research
Posted on: 02 September, 2021
The largest study of its type in Australia will investigate the impact of COVID-19 on younger patients with new trends emerging around the cardiac complications from the Delta strain of the virus.
Launched last year, the AUS-COVID trial assessed more than 640 patients in 21 hospitals across Australia, recording cardiovascular complications.
From this group, 125 were people were admitted to intensiv.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence
Posted on: 31 May, 2021
Two leading cardiovascular experts have been appointed to a prestigious world expert panel to reduce rates of cardiovascular disease in women.
Royal North Shore Hospital (RNSH) interventional cardiologist and Kolling Institute researcher, Professor Gemma Figtree, and RNSH senior hospital scientist and Kolling Institute researcher, Dr Anastasia Mihailidou, have been appointed commissioners of The La.....
Read more
Category: Cardiovascular and Renal Research
Posted on: 26 April, 2021
A team of researchers from the Kolling Institute, The University of Sydney, Monash University and La Trobe University have led a global call to action to accelerate new approaches for cardiovascular disease (CVD) drug solutions.
CVD is the leading cause of death globally. Since the start of the pandemic approximately 18 million people have died of CVD, with the majority from low- and middle-income .....
Read more
Category: Cardiovascular and Renal Research
Posted on: 14 April, 2021
Two of our leading researchers will drive key Australian projects following a funding announcement from the National Health and Medical Research Council. (NHMRC)
More than $1.4 million from the partnership grant program will go to Kolling researcher and RNSH interventional cardiologist Professor Gemma Figtree and her team for a study to reduce coronary artery disease. The world-first project will r.....
Read more
Category: Cardiovascular and Renal Research
Posted on: 14 December, 2020
Kolling researcher and Royal North Shore Hospital cardiologist Dr Rebecca Kozor will lead a world-first study using MRI technology to improve the diagnosis of heart failure.
The trial has been made possible following a $50,000 Cardiac Society of Australia and New Zealand-Boehringer Ingelheim innovation grant.
Dr Kozor has welcomed the funding to quantify pulmonary congestion or lung water density i.....
Read more
Category: Cardiovascular and Renal Research, Funding support
Posted on: 04 November, 2020
Professor Gemma Figtree has led a successful bid for a Cardiovascular Centre of Excellence, securing $2.5 million in funding from the National Health and Medical Research Council. (NHMRC)
Around 20 national and international collaborators will be involved in the research, targeting the global heart disease epidemic through new diagnostic techniques and prevention strategies.
Professor Figtree has w.....
Read more
Category: Cardiovascular and Renal Research, Funding support
Posted on: 15 July, 2020
Generous funding from the Raymond E Purves Foundation will support innovative research to identify how osteoarthritis causes cardiovascular disease.
$100,000 will go towards Dr Cindy Shu to continue her valuable project to better define the link between osteoarthritis and heart disease, and inform improved treatment.
Nearly 2.5 million Australians currently suffer from osteoarthritis, with the disa.....
Read more
Category: Funding support
Posted on: 09 August, 2019
Two Kolling Institute researchers have welcomed a significant funding boost through a large NSW Government program to help tackle Australia’s number one killer, heart disease.
Professors Gemma Figtree and Martin Ugander have each been awarded a $750,000 grant to encourage researchers to find breakthroughs and help establish NSW as a centre for research excellence.
The funding is part of a broader .....
Read more
Category: Funding support